SEC Form EFFECT filed by Lumos Pharma Inc.
$LUMO
Biotechnology: Pharmaceutical Preparations
Health Care
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 12, 2024 |
| Accession Number: | 0001193125-24-276550 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||